TickerFactsScreenerDevelopers

Protagenic Therapeutics, Inc.\new (PTIX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$1.14M2017: -$1.38M2018: -$1.07M2019: -$488.0K2020: -$1.35M2021: -$2.80M2022: -$1.99M2023: -$3.70M2024: -$4.22M2025: -$1.77M2026: -$2.81M-$2.81M
2016Operating Cash Flow (USD)2026
Fiscal YearOperating Cash FlowChange YoY
2026-$2.81M-58.7%
2025-$1.77M+58.0%
2024-$4.22M-13.8%
2023-$3.70M-85.8%
2022-$1.99M+28.8%
2021-$2.80M-107.5%
2020-$1.35M-176.4%
2019-$488.0K+54.4%
2018-$1.07M+22.4%
2017-$1.38M-21.0%
2016-$1.14M—